Table 1. Baseline characteristic of patients.
Characteristics | x±s |
Male (%) | 30.2 |
Age (a) | 54.8±9.4 |
Body mass index ( kg/m2) | 27.6±4.6 |
Duration of diabetes (a) | 7.52±6.1 |
Waist circumference (cm) | 98.4±12.7 |
Systolic blood pressure ( mm Hg) | 125.2±20.1 |
Diastolic blood pressure (mm Hg) | 76.9±11.7 |
FBS (mg/dL) | 173.8±70.3 |
HbA1C (%) | 8.7±1.9 |
Total cholesterol (mg/dL) | 175.9±39.8 |
Triglyceride (mg/dL) | 168.1±115.4 |
HDL cholesterol (mg/dL) | 41.9±7.0 |
LDL cholesterol (mg/dL) | 102.9±29.8 |
Creatinine (mg/dL) | 0.97±0.2 |
Ca (mg/dL) | 9.4±0.4 |
P (mg/dL) | 3.7±0.6 |
PTH (pg/mL) | 61.0±15.9 |
25 (OH) D (ng/mL) | 9.8±8.5 |
Urine albumin to creatinine ratio (micg/mg) | 47.9±78.0 |
Glumerolar filtration rate (mL/min) | 83.1±26.4 |
IGF1 | 104.4±44.5 |
High sensitive C-reactive protein | 3.0±3.7 |
Hypertension (%) | 56.7 |
Smoking (%) | 5.2 |
History of macrovascular disease (%) | 26.2 |
Retinopathy (%) | 35% (21.8% non-proliferative retinopathy, 7.7% proliferative retinopathy and 7.1% macular edema) |
FBS: Fasting blood glucose; HbA1C: Glycosylated hemoglobin; LDL: Low density lipoprotein; HDL: High density lipoprotein; PTH: Parathyroid hormone; 25(OH) D: 25 hydroxy vitamin D.
(n= 235)